FIGURE 1.

Audit of label claims^a: (A) All products by product type,^b (B) Full-spectrum products by product format, and (C) Unspecified^c products by product type. ^aThe audit of the products evaluated the proportion of the analyzed products that conformed with the label claim. Failure to meet the defining criteria could generally be attributed to a lack of phytocannabinoids other than THC; however, five products failed due to a lack of detectable CBD, and three broad-spectrum products had THC, of which two had >0.3% THC. ^bFull spectrum, broad spectrum, and CBD isolate are based on claims made on the product packaging. ^cProducts did not have a specific claim related to hemp content. CBD, cannabidiol; THC, tetrahydrocannabinol.